Larvol Delta - PRAC-adopted-updates-to-the-SmPC-and-Package-Leaflet-for-Padcev-to-support-an-extension-of-indication-in-combination-with-pembrolizumab-for-adults-with-muscleinvasive-bladder-cancer-eligible-for-cisplatincontaining-chemotherapy

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

Keytruda (pembrolizumab) - Merck (MSD)

https://www.ema.europa.eu/en/documents/agenda/agenda-prac-meeting-31-august-3-september-2026_en.pdf

Aug 31, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next